Harmonized multi-site MRI-based quantification of human liver fat and stiffness: a pilot study

Le résumé fourni par la source

Non-alcoholic fatty liver disease (NAFLD) is a leading cause of end-stage liver disease. NAFLD diagnosis and follow-up relies on a combination of clinical data, liver imaging, and/or liver biopsy. However, inter-site imaging differences impede diagnostic consistency and reduce the repeatability of the multi-site clinical trials necessary to develop effective treatments. The goal of this pilot study was to harmonize commercially available 3T magnetic resonance imaging (MRI) measurements of liver fat and stiffness in human participants across academic sites and MRI vendors.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.